NIMedical developed the whole body bioimpedance technology focusing on noninvasive assessment and monitoring of cardiovascular patients.
The NICaS, is design for use in Hospitals, by cardiologists in the community and by home Healthcare providers. its Regulatory Approvals: ISO 13485; US FDA, European CE Mark, Canadian MDL. Total global market opportunity is enormous, with significant recurring annual sensor revenue. Initially, our focus is on improving outcomes and decreasing cost of care for Heart Failure, Hypertension and CRT Pacemakers patients.